The landscape of cancer treatment is rapidly transforming through advances in immunotherapy, biomarker discovery, precision medicine, and personalized oncology approaches. The 2nd Immuno-Oncology & Biomarker Summit 2026 will take place on 19–20 October 2026 in Philadelphia, USA brings together leading scientists, clinicians, pharmaceutical executives, biotechnology innovators, diagnostics experts, and research organizations to explore the breakthroughs shaping the future of cancer care.
This premier conference provides a collaborative environment where industry leaders can exchange knowledge, present groundbreaking research, build partnerships, and discover opportunities that accelerate the development of next-generation immuno-oncology solutions.
Explore the Latest Advances Through a Cutting-Edge Conference Agenda
The summit agenda is designed to address the most important challenges and innovations in immuno-oncology and biomarker-driven cancer treatment.
Key discussion areas include:
- Next-generation immunotherapies and immune checkpoint strategies
- CAR-T, TCR, and engineered cell therapies for solid tumors
- Bispecific antibodies and immune engager platforms
- Cancer vaccines and personalized immunotherapy approaches
- Tumor microenvironment and immune resistance mechanisms
- Biomarker discovery and validation strategies
- Companion diagnostics (CDx) development
- AI, machine learning, and multi-omics in oncology research
- Spatial biology and single-cell technologies
- Liquid biopsy and precision oncology applications
- Clinical trial advancements and translational research
Through keynote presentations, expert-led panels, scientific presentations, and networking sessions, attendees will gain valuable insights into emerging technologies and strategies transforming the immuno-oncology ecosystem.
Connect with World-Class Experts and Industry Thought Leaders
The summit will feature an influential speaker faculty consisting of leading researchers, executives, and innovators from pharmaceutical companies, biotechnology organizations, academic institutions, and healthcare technology companies.
The speaker lineup includes experts such as:
- Rakesh Dixit – Co-Founder, President, CSO, Regio Biosciences
- Jun Ren – Senior Scientist, AstraZeneca
- Syed Kazmi – CEO, Magnacor Therapeutics
- Douglas Palmer – Executive Director Head IO Translational Medicine, AstraZeneca
- Kevin Horgan – Head. R&D, Melius MicroBiomics
- Pratik Rane – Director, CORE Oncology, Merck
- George Pell – Principal, Chief Strategy Officer, Seven
- Robert Kemp – President, MG Lifesciences
- Stefan Glueck – Chief Medical Officer, Konsuld
- Lokesh Agrawal – Chief (Acting) Biorepositories & Biospecimen Research Branch, National Cancer Institute, NIH
- Dr. Jennifer Onwumeh-Okwundu – Director, Clinical Science, Pfizer
- Sarbajit Mukherjee – Chief, GI Medical Oncology, Baptist Health South Florida
- Raluca Budiu-Predoiu – Director, Precision Medicine IO, CDx Strategy Lead, AbbVie
- Gary Steven Friedman – Chair, Biomarker Data Repository Oversight Committee, Critical Path Institute (C-Path)
- Usha Singh – Global Precision Medicine Dx Team Lead, Johnson & Johnson
- Dr. Ashok Srivastava – CEO, rTR Technovation Corporation
The conference will continue to bring together experts who are advancing novel therapies, biomarker strategies, clinical applications, and commercial opportunities in oncology.
Become a Speaker: Share Your Expertise with the Global Immuno-Oncology Community
Are you leading innovative research, developing breakthrough technologies, or advancing clinical solutions in immuno-oncology?
The summit provides an exclusive opportunity for researchers, clinicians, industry experts, and technology leaders to become part of the speaker community and share their expertise with a highly focused audience.
Speaking at the conference allows you to:
- Present your latest research findings and scientific discoveries
- Highlight your organization’s innovations and pipeline developments
- Engage with global experts and decision-makers
- Increase visibility among pharma, biotech, and healthcare leaders
- Contribute to discussions shaping the future of cancer immunotherapy
Experts working in immunotherapy, biomarkers, companion diagnostics, precision medicine, cell therapy, and translational oncology are invited to explore speaking opportunities and become a voice in the next generation of cancer innovation.
Become a Sponsor: Position Your Brand at the Forefront of Oncology Innovation
The 2nd Immuno-Oncology & Biomarker Summit 2026 offers strategic sponsorship opportunities for organizations looking to strengthen their presence within the global oncology community.
By becoming a sponsor, your organization can:
- Showcase your latest technologies, platforms, products, and services
- Connect with senior leaders from pharmaceutical and biotechnology companies
- Build valuable partnerships with researchers and healthcare innovators
- Generate new business opportunities through targeted networking
- Enhance brand visibility among a specialized scientific audience
- Demonstrate leadership in advancing cancer research and treatment solutions
Sponsorship opportunities are designed for companies working across:
- Immunotherapy development
- Biotechnology and pharmaceutical research
- Biomarker discovery platforms
- Companion diagnostics
- Clinical research solutions
- AI and healthcare technologies
- Laboratory and life science solutions
Whether you are launching a new technology, expanding your industry network, or seeking strategic collaborations, sponsoring the summit provides a powerful platform to connect with the right audience and create meaningful business impact.
Exhibit and Partner with Global Oncology Leaders
Organizations can also participate as exhibitors and strategic partners to showcase their solutions directly to researchers, decision-makers, and potential collaborators.
Exhibiting provides opportunities to:
- Demonstrate innovative products and technologies
- Meet potential partners and customers
- Build relationships with scientific and business leaders
- Increase awareness within the immuno-oncology marketplace
Be Part of the Future of Cancer Treatment
The 2nd Immuno-Oncology & Biomarker Summit 2026 is more than a conference—it is a meeting point for innovation, collaboration, and scientific progress.
Join the global community of researchers, clinicians, pharmaceutical leaders, biotech pioneers, and technology innovators working together to transform cancer treatment.
Become a Speaker. Become a Sponsor. Become a Partner. Be part of the future of immuno-oncology.
